Oncology Indications Can Be Cellular Targets Rather Than Organs, FDA Says

Cancer therapies can be indicated for tumors defined by cellular markers rather than conventional organ-specific targets, FDA Oncology Drug Products Division Director Richard Pazdur, MD, said during the American Society of Clinical Oncology annual meeting in New Orleans June 5